2ND ANNUAL BREAST CANCER SYMPOSIUM

Hudson, NY | September 25-26, 2020

Proudly Hosted by New York Oncology Hematology

DATE/LOCATION

September 25-26, 2020
Hudson Hall at the Historic Hudson Opera House
327 Warren Street
Hudson, NY 12534

Registration

BCS | Registration

If you are human, leave this field blank.

First Name *

Last Name *

Degree * Degree

Specialty (for healthcare professionals)

Institution *

Phone *

Email *

How did you hear about this conference? *

I plan to attend:

General Session
12:00pm – 5:30pm | Friday, September 25th, 2020

Tentative Ancillary CME Dinner Session*
5:30pm – 7:00pm | Friday, September 25th, 2020

General Session
7:00am – 3:00pm | Saturday, September 26th, 2020

Tentative Ancillary CME Lunch Session*
12:00pm – 1:00pm | Saturday, September 26th, 2020

Notice

** NOTICE ** 
You have selected one or more optional sessions.  Our team will reach out to you prior to the conference to communicate the topics and speakers.

Goal

Advances in breast cancer health have been growing exponentially during the twenty-first century and identification of novel therapeutic strategies have led to improved surgical and radiation outcomes. Actionable targets have identified smarter systemic therapies with improved, disease-free, overall survival benefits. In addition to awareness, addressing the health, emotional, and physical well-being of patients after breast cancer treatment have improved the overall quality of life for the patient and their families. As breast cancer is a multimodal disease, the purpose of this conference is to present the multiple facets that constitute the individual patient’s diagnosis, management, and treatment. The goal of this conference is to educate the medical and global community in a forum to foster communication that will benefit the individual patient as well as the community.

TARGET AUDIENCE

Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.

LEARNING OBJECTIVES

After completing this activity, participants should be better prepared to:

Review the modern surgical approaches addressed in the patient encounter

Discuss updates in breast cancer imaging for earlier detection

Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu overexpressing and triple negative breast cancer

Review advances in radiation therapy and outcomes

Identify risk factors and endocrine interventions in patients high risk for developing breast cancer

Discuss the role of hereditary genetics and the implication to the patient and their families

DOWNLOAD AGENDA

FEE INFORMATION

The fee for this educational activity is $250 for physicians and $50 for all other allied health professionals.

Registration Confirmation and Refund Policy:

Upon receipt of payment, your registration will be secured and a confirmation email will be provided. If requested, a full refund will be provided within 30 days of the conference.

Planning Committee

Maria Theodoulou, MD (Course Chair & Moderator)
Medical Oncologist
Breast Cancer Medicine
New York Oncology Hematology
Albany, NY

Ira Zackon, MD
Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH, PC
Clinical Assistant Professor
Albany Medical College
Albany, NY

FACULTY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
Lake Success, NY

Todd Doyle, MD
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

Chau T. Dang, MD
Chief, Westchester Medical
Oncology Service
Associate Attending
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
New York, NY

Yasmin Hasan, MD
UChicago Medicine

Claudine Isaacs, MD
Professor of Medicine
Associate Director, Clinical Research
Georgetown University
Washington, DC

Neil Iyengar, MD
Assistant Attending
Memorial Sloan Kettering Cancer Center
Associate Attending
Rockefeller University
Assistant Professor of Medicine
Weill Cornell Medicine
New York, NY

Eleftherios (Terry) Mamounas, MD, MPH
Medical Director, Comprehensive Breast Program
Orlando Health UF Health Care Center
Professor of Surgery
University of Central Florida
Orlando, FL

Babak Mehrara, MD
Memorial Sloan Kettering Cancer Center

Hyman B. Muss, MD
Mary Jones Hudson Distinguished Professor of Geriatric Oncology
Professor of Medicine: University of North Carolina
Director of Geriatric Oncology: Lineberger Comprehensive Cancer Center
Chapel Hill, NC

Larry Norton, MD
Memorial Sloan Kettering Cancer Center

Edith Perez, MD
Professor of Medicine
Mayo Clinic
Jacksonville, FL

George Plitas, MD
Associate Attending, Breast Service, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Mark Robson, MD
Memorial Sloan Kettering Cancer Center

Loren L. Rourke, MD, MHCM, FACS
Chief Surgical Officer, US Oncology Network
The Woodlands, TX

Andrew Seidman, MD
Memorial Sloan Kettering Cancer Center

Tiffany A. Traina, MD
Vice Chair, Oncology Care, Department of Medicine
Associate Attending Physician
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine
New York, NY

Beth E. Whiteside, MD
Assistant Professor of Radiology
Medical Director
Albany Medical Center
Albany, NY

Maria Theodoulou, MD (Course Director)

Medical Oncologist

New York Oncology Hematology

Albany, NY

Francis Arena, MD
Director, NYU Langone Arena Oncology
Clinical Professor, NYU Health Medical College
Lake Success, NY

Jeanne Carter, PhD
Head, Female Sexual Medicine and Women's Health Program
Memorial Sloan Kettering Cancer Center
New York, NY

Todd Doyle, MD
Director of Radiation Therapy
New York Oncology Hematology
Albany, NY

Hudson Hall at the Historic Hudson Opera House

327 Warren Street
Hudson, NY 12534

HOTEL ACCOMMODATIONS

Overnight accommodations at the Marriott Albany are offered at a special rate of $129/night. Hotel rooms are blocked for the nights of June 4 and 5, 2020. The hotel will extend the negotiated rate to the nights before and after the conference based upon availability.

MAKE YOUR RESERVATION

- You may also call the hotel directly to make your reservation at 518-458-8444 and mention Group Code: Med Ed BCS.
- Reservations must be made by May 14, 2020, to receive the special rate.
- Complimentary parking is available.
- Event staff will be glad to assist you with any special needs (physical, dietary, etc.). Contact us

HOST

The 2nd annual Breast Cancer Symposium is proudly hosted by New York Oncology Hematology, PC

ACCREDITATION

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Assurance of Balanced, Unbiased, and Fair Content:
It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

This Activity Is Planned By myMedEd, Inc.

Educational Partners

Accredited Provider: